Generic NameUS Trade NameDrug TypeFDA-Approved for JIAWarnings— Increased Risk
BetamethasoneCelestoneIntra-articular corticosteroidYesSubcutaneous atrophy ; Cushing syndrome
Triamcinolone AcetonideKenologIntra-articular corticosteroidYesSubcutaneous atrophy; Cushing syndrome
Triamcinolone HexacetonideAristospanIntra-articular corticosteroidNoSubcutaneous atrophy; Cushing syndrome
CelecoxibCelebrexNSAIDYesHepatotoxicity; nephrotoxicity; gastritis
EtodolacLodineNSAIDNoCardiovascular thrombotic events; gastritis
IbuprofenMotrin AdvilNSAIDYesGastritis; hepatotoxicity; nephrotoxicity
IndomethacinIndocin Indocin SRNSAIDYesHeadaches: gastritis; hepatotoxicity; nephrotoxicity
MeloxicamMobicNSAIDYesGastritis; hepatotoxicity; nephrotoxicity
NaproxenNaprosyn AleveNSAIDYesGastritis; hepatotoxicity; nephrotoxicity
OxaprozinDayproNSAIDYesCardiovascular thrombotic events; gastritis
TolmetinTolectinNSAIDYesGastritis; hepatotoxicity; nephrotoxicity

From: Appendix B, Screening Criteria

Cover of Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis (JIA)
Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis (JIA) [Internet].
Comparative Effectiveness Reviews, No. 28.
Kemper AR, Coeytaux R, Sanders GD, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.